| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 毛冬青皂苷B2; Ilexsaponin B2 | CFN93153 | 108906-69-0 | C47H76O17 = 913.10 | 5mg | QQ客服：215959384 |
| 灵芝酸D2; Ganoderic acid D2 | CFN93157 | 97653-94-6 | C30H42O8 = 530.65 | 5mg | QQ客服：1413575084 |
| 川续断皂苷IV; Asperosaponin IV | CFN93167 | 126778-93-6 | C49H78O19 = 971.14 | 5mg | QQ客服：1413575084 |
| 5,6-脱氢人参皂苷Rd; 5,6-Dehydroginsenoside Rd | CFN93170 | 1268459-68-2 | C48H80O18 = 945.15 | 5mg | QQ客服：1457312923 |
| 新黄芪皂苷 I; Neoastragaloside I | CFN93176 | 1324005-51-7 | C45H72O16 = 869.05 | 5mg | QQ客服：3257982914 |
| 异黄芪皂苷Ⅳ; Isoastragaloside IV | CFN93177 | 136033-55-1 | C41H68O14 = 784.98 | 5mg | QQ客服：215959384 |
| 拟人参皂苷Rh2; Pseudoginsenoside Rh2 | CFN93178 | 1370264-16-6 | C36H62O8 = 622.88 | 5mg | QQ客服：2159513211 |
| 越南人参皂苷R4; Vinaginsenoside R4 | CFN93193 | 156009-80-2 | C48H82O19 = 963.16 | 10mg | QQ客服：3257982914 |
| 越南人参皂苷R3; Vinaginsenoside R3 | CFN93194 | 156012-92-9 | C48H82O17 = 931.16 | 5mg | QQ客服：1457312923 |
| 越南人参皂苷R8; Vinaginsenoside R8 | CFN93195 | 156042-22-7 | C48H82O19 = 963.16 | 5mg | QQ客服：2159513211 |
| 绞股蓝皂苷A; Gypenoside A | CFN93197 | 157752-01-7 | C46H74O17 = 899.08 | 5mg | QQ客服：3257982914 |
| 知母皂苷I; Anemarrhenasaponin I | CFN93200 | 163047-21-0 | C39H66O14 = 758.94 | 20mg | QQ客服：2159513211 |
| 赤芝酸B; Lucidenic acid B | CFN93202 | 95311-95-8 | C27H38O7 = 474.59 | 5mg | QQ客服：1457312923 |
| 异人参皂苷Rh3; Isoginsenoside Rh3 | CFN93203 | 166040-90-0 | C36H60O7 = 604.86 | 5mg | QQ客服：2056216494 |
| 黄花败酱皂甙C; Scabioside C | CFN93205 | 17233-22-6 | C41H66O13 = 766.96 | 5mg | QQ客服：2056216494 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)